Chemical ablation of liver cancer.
Percutaneous chemical ablation is an established image-guided therapy for liver cancer that is relatively simple to perform and requires no specialized equipment. Chemical ablation has been used extensively for hepatocellular carcinoma (HCC), and has achieved outcomes comparable to surgical resection for small, solitary HCC. More recent experience with chemical ablation has combined it with TACE or thermal ablation as part of a multimodality approach to liver cancer.
Clark
Timothy W I
TW
Department of Radiology, New York University School of Medicine, New York, NY 10016, USA. timothy.clark@med.nyu.edu
D019342:Acetic Acid / Q000008:administration & dosage*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D017115:Catheter Ablation; D000431:Ethanol / Q000008:administration & dosage*; D006801:Humans; D015552:Injections, Intralesional; D008113:Liver Neoplasms / Q000188:drug therapy*; D009364:Neoplasm Recurrence, Local; D018579:Patient Selection; D015641:Radiography, Interventional; D012307:Risk Factors; D016019:Survival Analysis; D014057:Tomography, X-Ray Computed; D018084:Ultrasonography, Interventional
D000431:Ethanol; D019342:Acetic Acid